Rejko Krüger
Working Groups
- Member, Underrepresented Populations Working Group
- Member, Steering Committee
- Member, اللجنة التوجيهية
Biography
Rejko Krüger is Professor for Clinical and Experimental Neuroscience at the University of Luxembourg and Director of Transversal Translational Medicine at the Luxembourg Institute of Health. His work is supported by an Excellence Award for Research in Luxembourg of the Fonds National de Recherche (FNR; PEARL). Since June 2019 he links between the Luxembourg Institute of Health (LIH) and the Luxembourg Centre for Systems Biomedicine (LCSB) to contribute to personalised medicine by implementing translational research programmes involving partners from different fields within a joint scientific strategy.
Within his position Rejko Krüger integrates expertise in (i) fundamental research on neurodegeneration (https://kruegerlab.uni.lu) and (ii) clinical research as Coordinator of the National Centre of Excellence in Research on Parkinson’s disease (NCER-PD; http://www.parkinson.lu) funded by the FNR.
Research interests focus on the elucidation of molecular signalling pathways underlying common neurodegenerative diseases using patient-based cellular models. A unique fully automated platform for high content-/ high throughput-screening of drugs on stem-cell derived neurons has been established to identify neuroprotective compounds for precision medicine (http://wwwen.uni.lu/lcsb/research/clinical_experimental_neuroscience/platform).
His clinical and research experience extends over more than 20 years and resulted in more than 150 scientific publications (>33.000 citations; H Factor 64).
In 2018 he launched new concepts for integrative care on neurodegenerative diseases in Luxembourg, including Parkinson’s disease (www.parkinsonnet.lu) and the prevention of dementia (www.demenz.lu).